Liquid biopsy using extracellular vesicle-derived DNA in lung adenocarcinoma
Blood liquid biopsy has emerged as a way of overcoming the clinical limitations of repeat biopsy by testing for the presence of acquired resistance mutations to therapeutic agents. Despite its merits of repeatability and non-invasiveness, this method is currently only used as a supplemental test due...
Saved in:
Main Authors: | In Ae Kim (Author), Jae Young Hur (Author), Hee Joung Kim (Author), Seung Eun Lee (Author), Wan Seop Kim (Author), Kye Young Lee (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA
by: Shan Guo, et al.
Published: (2024) -
Extracellular Vesicles and the Promise of Continuous Liquid Biopsies
by: Don Armstrong, et al.
Published: (2018) -
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
by: Sunhee Chang, et al.
Published: (2020) -
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
by: Karama Asleh, et al.
Published: (2023) -
The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression
by: Henok D. Habtemariam, et al.
Published: (2022)